Compare Corona Remedies with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
INR 9,966 Cr (Small Cap)
50.00
31
0.00%
-0.01
24.61%
16.31
Total Returns (Price + Dividend) 
Corona Remedies for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27-Feb-2026 | Source : BSEIntimation of Schedule of Analyst / Investor Meeting
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17-Feb-2026 | Source : BSEIntimation of participation in Analyst / Investor Conference
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
10-Feb-2026 | Source : BSETranscript of Earnings Conference Call with Analyst / Investor on Financial Results for the third quarter and nine months ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 13 Schemes (6.38%)
Held by 18 FIIs (1.84%)
Ankurbhai K Mehta (22.0%)
Sepia Investments Limited (19.76%)
1.36%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -5.18% vs 4.21% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -20.90% vs 12.39% in Sep 2025






